Table 1.
The baseline characteristics of the two identified study cohorts exposed to statins.
| Simvastatin (BioVU) | Atorvastatin (PMRP) | |
|---|---|---|
| N | 2026 | 2252 |
| Age | 58.8 ± 12.4 | 62.21±12.84 |
| Ancestry (European Americans) | 77.05% | 98.20% |
| Gender (Female) | 52.12% | 51.82% |
The baseline characteristics of the two identified study cohorts exposed to statins.
| Simvastatin (BioVU) | Atorvastatin (PMRP) | |
|---|---|---|
| N | 2026 | 2252 |
| Age | 58.8 ± 12.4 | 62.21±12.84 |
| Ancestry (European Americans) | 77.05% | 98.20% |
| Gender (Female) | 52.12% | 51.82% |